Glenmark Pharmaceuticals inducted into the Dow Jones Sustainability Indices

Glenmark Pharmaceuticals has been listed on the Dow Jones Sustainability Indices (DJSI) 2018.

DJSI is one of the most esteemed global benchmarks for sustainable business practices. Only the top ranked companies in terms of corporate sustainability within each industry are selected to be featured in the index. The inclusion in this list is considered highly prestigious by global investors, financial analysts and other stakeholders and also serves as a benchmark for investors who integrate sustainability considerations into their port-folios. Speaking on the achievement, Mr. Glenn Saldanha, Chairman and Managing Director said, “Being listed in the index is a landmark achievement for us and it re-emphasises our efforts towards environment, social and governance factors and how over the years we have emerged as a leader in the area of sustainability.”

The ‘DJSI Emerging Market’ leaders were chosen from over 800 companies who were assessed, out of which 94 made it to the Index. Glenmark is among the only two pharmaceutical companies to be featured in the ‘Emerging Market Index’. From India there are only 10 companies who have made it to this prestigious listing.

The evaluation included 24 long-term economic, environmental and social criteria. Glenmark secured high scores for marketing practices, product quality and recall, environmental policy and management system, corporate citizenship and philanthropy, health outcome contribution and code of business conduct.